Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A nop56 Zebrafish Loss-of-Function Model Exhibits a Severe Neurodegenerative Phenotype

  • Quelle Regaldie, Ana
  • Folgueira, Mónica
  • Yáñez, Julián
  • Sobrido Cameán, Daniel
  • Alba-González, Anabel
  • Barreiro-Iglesias, Antón
  • Sobrido, María-Jesús
  • Sánchez Piñón, Laura
This article belongs to the Special Issue Animal Models of Neurological Disorders: Where Are We Now?, [Abstract] NOP56 belongs to a C/D box small nucleolar ribonucleoprotein complex that is in charge of cleavage and modification of precursor ribosomal RNAs and assembly of the 60S ribosomal subunit. An intronic expansion in NOP56 gene causes Spinocerebellar Ataxia type 36, a typical late-onset autosomal dominant ataxia. Although vertebrate animal models were created for the intronic expansion, none was studied for the loss of function of NOP56. We studied a zebrafish loss-of-function model of the nop56 gene which shows 70% homology with the human gene. We observed a severe neurodegenerative phenotype in nop56 mutants, characterized mainly by absence of cerebellum, reduced numbers of spinal cord neurons, high levels of apoptosis in the central nervous system (CNS) and impaired movement, resulting in death before 7 days post-fertilization. Gene expression of genes related to C/D box complex, balance and CNS development was impaired in nop56 mutants. In our study, we characterized the first NOP56 loss-of-function vertebrate model, which is important to further understand the role of NOP56 in CNS function and development., This research was funded by Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (Spain), grant number: PI17/01582. Grant PID2020-115121GB-I00 funded by MCIN/AEI/10.13039/501100011033 to Laura Sánchez and Antón Barreiro-Iglesias. Anabel Alba-González is recipient of a Predoctoral Felloeship from Xunta de Galicia (Grant number ED481A-2019/003), Xunta de Galicia; ED481A-2019/003
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Severe Neurometabolic Phenotype in NPC1−/− Zebrafish With a C-Terminal Mutation

  • Quelle Regaldie, Ana
  • Gandoy-Fieiras, Nerea
  • Villamayor, Paula R.
  • Maceiras, Sandra
  • Losada, Ana
  • Folgueira, Mónica
  • Cabezas Sáinz, Pablo
  • Barreiro-Iglesias, Antón
  • Villar López, María
  • Quiroga-Berdeal, María Isabel
  • Sánchez, Laura
  • Sobrido, María-Jesús
[Abstract] Niemann Pick disease type C (NPC) is an autosomal recessive neurodegenerative lysosomal disorder characterized by an accumulation of lipids in different organs. Clinical manifestations can start at any age and include hepatosplenomegaly, intellectual impairment, and cerebellar ataxia. NPC1 is the most common causal gene, with over 460 different mutations with heterogeneous pathological consequences. We generated a zebrafish NPC1 model by CRISPR/Cas9 carrying a homozygous mutation in exon 22, which encodes the end of the cysteine-rich luminal loop of the protein. This is the first zebrafish model with a mutation in this gene region, which is frequently involved in the human disease. We observed a high lethality in npc1 mutants, with all larvae dying before reaching the adult stage. Npc1 mutant larvae were smaller than wild type (wt) and their motor function was impaired. We observed vacuolar aggregations positive to cholesterol and sphingomyelin staining in the liver, intestine, renal tubules and cerebral gray matter of mutant larvae. RNAseq comparison between npc1 mutants and controls showed 284 differentially expressed genes, including genes with functions in neurodevelopment, lipid exchange and metabolism, muscle contraction, cytoskeleton, angiogenesis, and hematopoiesis. Lipidomic analysis revealed significant reduction of cholesteryl esters and increase of sphingomyelin in the mutants. Compared to previously available zebrafish models, our model seems to recapitulate better the early onset forms of the NPC disease. Thus, this new model of NPC will allow future research in the cellular and molecular causes/consequences of the disease and on the search for new treatments., This research was funded by Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (Spain), grant number: PI17/01582 to M-JS. Grant PID2020-115121GB-I00 funded by MCIN/AEI/10.13039/501100011033 to LS and AB-I. Additional funds were donated by “Asociación Galega de Ataxias” (AGA)